DLXY Stock Explodes 389% On Kazakhstan Oil Field Deal

Delixy Holdings Limited faces heightened selling pressure after negative earnings revision, as its stocks have been trading down by -42.79 percent.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading DLXY

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Delixy signed a non-binding letter of intent with Caog to buy or merge into up to 48% of Tarbagatay Munay, operator of the Sarybulak Oil Field in East Kazakhstan.
After the announcement, DLXY shares spiked roughly 389% in a single session, signaling aggressive momentum trading.
If closed, the deal would give Delixy a major foothold in an operating oil asset, but the agreement is still non-binding.

Live Update At 07:47:01 EDT: On Thursday, September 17, 2026 Delixy Holdings Limited stock [NASDAQ: DLXY] is trending down by -42.79%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

DLXY just showed traders what a true low-priced breakout looks like. Delixy Holdings Limited had been grinding between roughly $0.35 and $0.45 for weeks. On 2026/09/15, DLXY closed at about $0.42. Then the news hit. On 2026/09/16, the stock opened near $1.02, ripped to an intraday high above $4.40, and closed around $2.29. That is the 389% surge in action — pure momentum.

Under the surface, Delixy is tiny. The latest balance sheet shows total assets of about $24.9M against total liabilities of roughly $24.8M. Equity is only about $105,000. Working capital is thin at $88,000. DLXY does post solid revenue — around $307.7M — but the leverage ratio of 237 shows a highly geared structure.

More Breaking News

Valuation metrics look distorted at these prices. With a price-to-sales ratio of 0.02 and price-to-book near 5.01, DLXY is trading like a classic story stock. The market is not paying for current balance sheet strength. It is paying for the new oil field story and the chance of follow-through once the letter of intent moves, or fails to move, toward a real deal.

Why Traders Are Watching DLXY After The 389% Spike

DLXY just reminded the market what happens when a microcap name drops a big asset headline. Delixy Holdings Limited announced a non-binding letter of intent with Caog to pick up or merge into as much as 48% of Tarbagatay Munay, the operator of the Sarybulak Oil Field in East Kazakhstan. That one line changed the whole tape for DLXY.

Before this, DLXY was a sleepy sub-dollar ticker with modest volume and tight intraday ranges. The daily chart shows days stuck in the $0.35–$0.45 band, with closes like $0.38, $0.40, $0.42. Then, on 2026/09/16, it turned into a momentum playground. The stock touched $4.45 at the high after starting the prior day under $0.45. That is the type of range expansion momentum traders wait months to see.

Intraday, the 5‑minute chart on DLXY tells the story of a blow-off move. Early in the session, the stock spiked above $2, then pulled back, churned between roughly $1.50 and $1.70, and later settled in the $1.30–$1.40 area. For active trading, that kind of intraday range — with repeated bounces and fades — is ideal for scalpers and pattern traders.

But every serious trader should underline one phrase in this Delixy headline: “non-binding letter of intent.” DLXY does not yet own 48% of Tarbagatay Munay. This is not a closed acquisition of the Sarybulak Oil Field operator. It is the start of a negotiation that may or may not end in a definitive agreement. That gap between headline hype and execution reality is where both opportunity and risk live for DLXY traders.

Conclusion

DLXY is now on every momentum trader’s radar, and for good reason. In one day, Delixy Holdings Limited shifted from a quiet microcap to a 389% breakout driven by a potential deal for up to 48% of an operating East Kazakhstan oil field company. The market re-rated DLXY based on future optionality, not on the current balance sheet, which still shows razor-thin equity and heavy leverage.

For short-term traders, DLXY is now all about price action, liquidity, and news flow around that letter of intent. If Delixy moves from non-binding terms to a signed, definitive agreement with Caog and Tarbagatay Munay, the story gains real weight. If talks stall, DLXY can deflate just as fast as it spiked. Either way, the volatility alone creates trading setups.

The key is discipline and preparation. As Tim Bohen, lead trainer with StocksToTrade says, “Preparation is half the trade. By the time the bell rings, my decisions are nearly made.” DLXY is a textbook example of why rule-based trading matters. In the words often repeated by Tim Sykes, “The best traders are cowards — we cut losses quickly and let the numbers, not emotions, guide our decisions.” Delixy Holdings Limited and DLXY now offer a live case study in how hype, headlines, and risk management collide — perfect material for traders who want to learn, study the chart, and trade smarter.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!